Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Fang Li
Onderzoeker
,
Faculty of Science and Engineering
,
PharmacoTherapy, Epidemiology and Economics
https://orcid.org/0000-0002-2651-8401
Email
f.li
rug
nl
A Deusinglaan1
9713 AV
Groningen
Netherlands
Overview
Fingerprint
Network
Research output
(5)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Fang Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Scoping Review
97%
Health Economic Model
87%
Complication Prediction
87%
Pharmacist Intervention
87%
Community Pharmacists
87%
Middle-income Countries
87%
Review Method
87%
Early Symptom Change
87%
Comparative Analysis of Algorithms
87%
Low-income
87%
Type 2 Diabetic Patients
87%
Prediction Model
77%
Community Setting
25%
Face-to-face Counseling
25%
Multicomponent Intervention
25%
Diabetes Management
25%
Embase
22%
High-income Countries
12%
Remote Consultation
12%
Printing Materials
12%
Community Pharmacy
12%
Primary Care Setting
12%
Primary Care Centers
12%
Single Component
12%
Poor Quality
12%
Intervention Group
12%
Interrupted Time Series Design
12%
Health Tools
12%
National Institutes of Health
12%
Clinical Patients
12%
Pharmacist Role
12%
Safety Outcomes
12%
Cochrane Central Register of Controlled Trials
12%
Improved Outcomes
12%
Most Common Form
12%
PubMed
12%
Type 2 Diabetes Mellitus Patients
12%
Medication Review
12%
Medication Safety
12%
Design Study
12%
Language of Publication
12%
Specific Interventions
12%
Naturalistic Dataset
10%
Machine Learner
10%
Discrete Event Simulation
9%
Diabetes Type 2
9%
Cochrane
9%
Simultaneous Evaluation
9%
Prediction Method
9%
Medicine and Dentistry
Cost-Effectiveness Analysis
87%
Primary Health Care
87%
Diabetes
87%
Health Care Cost
87%
Counseling
87%
Patient with Type 2 Diabetes
87%
Drug Therapy
87%
Treatment Duration
87%
Maturity Onset Diabetes of the Young
87%
Quality Adjusted Life Year
70%
Consultation
43%
Time Series Analysis
43%
Community Pharmacy
43%
Patient Preference
17%
Client
17%
Bootstrapping
17%